Ad

EBR – EBR Systems Inc

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month

Ad

Recommendation Rating

2.5

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 0.65

Low: 0.19

High: 1

Total Analysts: 4

Company Profile

EBR Systems, Inc. is engaged in delivering treatment for patients suffering from cardiac rhythm diseases. The Company is providing physiological stimulation through wireless cardiac pacing. The Company is developing and commercializing WiSE, an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. Its three common therapeutic customer relationship management (CRM) devices include Pacemakers, Defibrillators and Cardiac Resynchronization Therapy (CRT) devices. The Company offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company’s subsidiaries include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses